Letter | Published:

Induction of cell death by endogenous nerve growth factor through its p75 receptor

Nature volume 383, pages 166168 (12 September 1996) | Download Citation

Subjects

Abstract

DURING development, neuronal survival is regulated by the limited availability of neurotrophins, which are proteins of the nerve growth factor (NGF) family. Activation of specific trk tyrosine kinase receptors by the neurotrophins blocks programmed cell death. The trkA-specific ligand NGF has also been shown to activate the non-tyrosine kinase receptor p75, a member of the tumour necrosis factor (TNF) receptor and Fas (APO-1/CD95) family. Here we report that, early in development, endogenous NGF causes the death of retinal neurons that express p75 but not trkA. These results indicate that, as with cells of the immune system, the death of neurons in the central nervous system can also be induced by ligands, and that the effect of NGF on cell fate depends on the type of receptor expressed by developing neurons.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Annu. Rev. Neurosci. 14, 453–501 (1991).

  2. 2.

    & Annu. Rev. Neurosci. 19, 289–317 (1996).

  3. 3.

    J. Neurobiol. 25, 1386–1403 (1994).

  4. 4.

    , & Development 122, 1165–1174 (1996).

  5. 5.

    & Dev. Biol. 56, 110–156 (1977).

  6. 6.

    et al. Science 272, 542–545 (1996).

  7. 7.

    , & J. Comp. Neurol. 310, 103–129 (1991).

  8. 8.

    & Anat Embryol. 178, 543–551 (1988).

  9. 9.

    et al. Development 103, 545–552 (1988).

  10. 10.

    et al. J. Immunol. 153, 1778–1788 (1994).

  11. 11.

    et al. J. Neurosci. 16, 4402–4410 (1996).

  12. 12.

    & Neuron 6, 649–663 (1991).

  13. 13.

    et al. Neuron 12, 639–654 (1994).

  14. 14.

    , , , & Nature 360, 757–759 (1992).

  15. 15.

    , , & Neuron 2, 1605–1613 (1989).

  16. 16.

    et al. Science 261, 345–348 (1993).

  17. 17.

    & Proc. Natl Acad. Sci. USA 91, 6501–6505 (1994).

  18. 18.

    , , & Nature 372, 684–686 (1994).

  19. 19.

    & Science 255, 1441–1443 (1992).

  20. 20.

    et al. J. Neurosci. 14, 1795–1811 (1994).

  21. 21.

    & J. Morphol. 88, 49–92 (1951).

  22. 22.

    , & EMBO J. 5, 1483–1487 (1986).

  23. 23.

    , , & Mol. Cell. Neurosci. 6, 544–556 (1995).

  24. 24.

    et al. Biochemistry 22, 1605–1613 (1983).

  25. 25.

    , & Development 120, 1613–1619 (1994).

Download references

Author information

Author notes

    • Alfredo Rodríguez-Tébar

    Cajal Institute, CSIC, Doctor Arce 37, E-28002 Madrid, Spain

Affiliations

  1. Max-Planck Institute for Psychiatry, Department of Neurobiochemistry, 82152 Planegg-Martinsried, Germany

    • José María Frade
    • , Alfredo Rodríguez-Tébar
    •  & Yves-Alain Barde

Authors

  1. Search for José María Frade in:

  2. Search for Alfredo Rodríguez-Tébar in:

  3. Search for Yves-Alain Barde in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/383166a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.